Apatinib in Combination With S-1 as Second-Line Treatment in Patients With Advanced Gastric Cancer

NCT03276156 · clinicaltrials.gov ↗

PHASE1

Phase

UNKNOWN

Status

12

Enrollment

OTHER

Sponsor class

Conditions

Gastric Cancer

Interventions

DRUG: Apatinib plus S-1

Sponsor

Zhejiang Cancer Hospital

Collaborators

[object Object]